Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects

The human albumin gene, the most abundant serum protein, is located in the long arm of chromosome 4, near the centromere, position 4q11–3. It is divided by 14 intervening introns into 15 exons, the last of which is untranslated. To date, 74 nucleotide substitutions (mainly missense) have been report...

Full description

Bibliographic Details
Main Authors: Gianluca Caridi, Francesca Lugani, Andrea Angeletti, Monica Campagnoli, Monica Galliano, Lorenzo Minchiotti
Format: Article
Language:English
Published: MDPI AG 2022-01-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/23/3/1159
_version_ 1797487604749303808
author Gianluca Caridi
Francesca Lugani
Andrea Angeletti
Monica Campagnoli
Monica Galliano
Lorenzo Minchiotti
author_facet Gianluca Caridi
Francesca Lugani
Andrea Angeletti
Monica Campagnoli
Monica Galliano
Lorenzo Minchiotti
author_sort Gianluca Caridi
collection DOAJ
description The human albumin gene, the most abundant serum protein, is located in the long arm of chromosome 4, near the centromere, position 4q11–3. It is divided by 14 intervening introns into 15 exons, the last of which is untranslated. To date, 74 nucleotide substitutions (mainly missense) have been reported, determining the circulating variants of albumin or pre-albumin. In a heterozygous state, this condition is known as alloalbuminaemia or bisalbuminaemia (OMIM # 103600). The genetic variants are not associated with disease, neither in the heterozygous nor in the homozygous form. Only the variants resulting in familial dysalbuminaemic hyperthyroxinaemia and hypertriiodothyroninaemia are of clinical relevance because affected individuals are at risk of inappropriate treatment or may have adverse drug effects. In 28 other cases, the pathogenic variants (mainly affecting splicing, nonsense, and deletions), mostly in the homozygous form, cause a premature stop in the synthesis of the protein and lead to the condition known as congenital analbuminaemia. In this review, we will summarize the current knowledge of genetic and molecular aspects, functional consequences and potential therapeutic uses of the variants. We will also discuss the molecular defects resulting in congenital analbuminaemia, as well as the biochemical and clinical features of this rare condition
first_indexed 2024-03-09T23:50:02Z
format Article
id doaj.art-d240e21d55584ed3b05a8d00adaa8a6d
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-09T23:50:02Z
publishDate 2022-01-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-d240e21d55584ed3b05a8d00adaa8a6d2023-11-23T16:36:00ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672022-01-01233115910.3390/ijms23031159Variations in the Human Serum Albumin Gene: Molecular and Functional AspectsGianluca Caridi0Francesca Lugani1Andrea Angeletti2Monica Campagnoli3Monica Galliano4Lorenzo Minchiotti5UOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, ItalyUOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, ItalyUOC Nefrologia e Trapianto Rene, Laboratorio di Nefrologia Molecolare, Istituto Giannina Gaslini IRCCS, 16147 Genova, ItalyDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, ItalyDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, ItalyDepartment of Molecular Medicine, University of Pavia, 27100 Pavia, ItalyThe human albumin gene, the most abundant serum protein, is located in the long arm of chromosome 4, near the centromere, position 4q11–3. It is divided by 14 intervening introns into 15 exons, the last of which is untranslated. To date, 74 nucleotide substitutions (mainly missense) have been reported, determining the circulating variants of albumin or pre-albumin. In a heterozygous state, this condition is known as alloalbuminaemia or bisalbuminaemia (OMIM # 103600). The genetic variants are not associated with disease, neither in the heterozygous nor in the homozygous form. Only the variants resulting in familial dysalbuminaemic hyperthyroxinaemia and hypertriiodothyroninaemia are of clinical relevance because affected individuals are at risk of inappropriate treatment or may have adverse drug effects. In 28 other cases, the pathogenic variants (mainly affecting splicing, nonsense, and deletions), mostly in the homozygous form, cause a premature stop in the synthesis of the protein and lead to the condition known as congenital analbuminaemia. In this review, we will summarize the current knowledge of genetic and molecular aspects, functional consequences and potential therapeutic uses of the variants. We will also discuss the molecular defects resulting in congenital analbuminaemia, as well as the biochemical and clinical features of this rare conditionhttps://www.mdpi.com/1422-0067/23/3/1159genetic variantsstructural changesstability: ligand bindingpharmacokineticscongenital analbuminaemia
spellingShingle Gianluca Caridi
Francesca Lugani
Andrea Angeletti
Monica Campagnoli
Monica Galliano
Lorenzo Minchiotti
Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
International Journal of Molecular Sciences
genetic variants
structural changes
stability: ligand binding
pharmacokinetics
congenital analbuminaemia
title Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
title_full Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
title_fullStr Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
title_full_unstemmed Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
title_short Variations in the Human Serum Albumin Gene: Molecular and Functional Aspects
title_sort variations in the human serum albumin gene molecular and functional aspects
topic genetic variants
structural changes
stability: ligand binding
pharmacokinetics
congenital analbuminaemia
url https://www.mdpi.com/1422-0067/23/3/1159
work_keys_str_mv AT gianlucacaridi variationsinthehumanserumalbumingenemolecularandfunctionalaspects
AT francescalugani variationsinthehumanserumalbumingenemolecularandfunctionalaspects
AT andreaangeletti variationsinthehumanserumalbumingenemolecularandfunctionalaspects
AT monicacampagnoli variationsinthehumanserumalbumingenemolecularandfunctionalaspects
AT monicagalliano variationsinthehumanserumalbumingenemolecularandfunctionalaspects
AT lorenzominchiotti variationsinthehumanserumalbumingenemolecularandfunctionalaspects